|
|
|
Insider
Information: |
Monia Brett P |
Relationship: |
Director |
City: |
Carlsbad |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
180,289 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$6,788,557 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
180,289 |
|
|
Total
Value |
$6,788,557 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
9
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
7
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-99.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ionis Pharmaceuticals Inc |
IONS |
CEO Level 15, Director |
2024-02-29 |
174,289 |
2012-01-01 |
0 |
Premium* |
|
Cognition Therapeutics Inc |
CGTX |
Director |
2023-06-09 |
6,000 |
2023-06-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
116 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
|
2020-08-31 |
4 |
A |
$44.46 |
$10,491 |
D/D |
236 |
29,193 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
|
2021-03-01 |
4 |
AS |
$54.28 |
$12,809 |
D/D |
(236) |
50,114 |
0 |
% |
|
IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
|
2021-02-26 |
4 |
A |
$44.54 |
$11,001 |
D/D |
247 |
50,350 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
|
2016-07-01 |
4 |
A |
$20.76 |
$6,414 |
D/D |
309 |
8,002 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
|
2017-01-01 |
4 |
A |
$20.76 |
$6,414 |
D/D |
309 |
8,181 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
|
2017-01-03 |
4 |
AS |
$48.60 |
$15,017 |
D/D |
(309) |
7,872 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
|
2017-07-03 |
4 |
AS |
$51.35 |
$15,867 |
D/D |
(309) |
11,626 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
|
2012-07-01 |
4 |
A |
$6.13 |
$1,906 |
D/D |
311 |
5,971 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
VP, Antisense Drug Discovery |
|
2013-01-03 |
4 |
AS |
$10.84 |
$3,371 |
D/D |
(311) |
5,288 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
|
2020-02-29 |
4 |
A |
$43.16 |
$13,553 |
D/D |
314 |
28,957 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
|
2020-09-01 |
4 |
AS |
$53.70 |
$16,862 |
D/D |
(314) |
28,879 |
0 |
% |
|
IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
|
2013-01-16 |
4 |
S |
$14.00 |
$4,620 |
D/D |
(330) |
5,695 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
|
2021-08-31 |
4 |
A |
$33.80 |
$11,998 |
D/D |
355 |
50,469 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
|
2022-04-01 |
4 |
AS |
$37.49 |
$13,309 |
D/D |
(355) |
88,662 |
0 |
% |
|
IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
|
2013-07-01 |
4 |
A |
$9.20 |
$3,329 |
D/D |
362 |
6,057 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
|
2014-01-02 |
4 |
AS |
$39.25 |
$14,210 |
D/D |
(362) |
486 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
|
2024-02-16 |
4 |
S |
$44.49 |
$17,219 |
D/D |
(387) |
173,751 |
0 |
% |
|
IONS |
Ionis Pharmaceuticals Inc |
CEO Level 15 |
|
2024-02-29 |
4 |
A |
$34.43 |
$18,521 |
D/D |
538 |
174,289 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Senior Vice President |
|
2012-01-01 |
4 |
D |
$6.13 |
$3,597 |
D/D |
(587) |
5,660 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
|
2012-07-03 |
4 |
AS |
$12.92 |
$7,584 |
D/D |
(587) |
5,384 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
|
2022-02-28 |
4 |
A |
$28.37 |
$17,620 |
D/D |
621 |
89,017 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
|
2013-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
737 |
5,790 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
|
2014-01-16 |
4 |
S |
$47.08 |
$38,653 |
D/D |
(821) |
1,816 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
|
2021-01-28 |
4 |
D |
$60.69 |
$79,261 |
D/D |
(1,306) |
50,103 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
|
2015-01-16 |
4 |
S |
$67.96 |
$104,257 |
D/D |
(1,534) |
4,426 |
0 |
- |
|
116 Records found
|
|
Page 2 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|